Bioventus Total Assets from 2010 to 2025

BVS Stock

USD 9.65 0.09 0.92%

Bioventus Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2016-03-31

Previous Quarter

769.5 M

Current Value

728 M

Quarterly Volatility

316.2 M

Yuan Drop

Covid

Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Total Revenue of 411.2 M, Gross Profit of 303.8 M or Other Operating Expenses of 390.2 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 4.0E-4 or PTB Ratio of 5.28. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.

Check out the analysis of Bioventus Correlation against competitors.

For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Latest Bioventus' Total Assets Growth Pattern

Below is the plot of the Total Assets of Bioventus over the last few years. Total assets refers to the total amount of Bioventus assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bioventus books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bioventus' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 727.96 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Bioventus Total Assets Regression Statistics

	Arithmetic Mean	616,375,726
	Geometric Mean	567,131,436
	Coefficient Of Variation	48.48
	Mean Deviation	230,704,249
	Median	472,407,000
	Standard Deviation	298,831,807
	Sample Variance	89300.4T
	Range	942.2M
	R-Value	0.65
	Mean Square Error	55607.4T
	R-Squared	0.42
	Significance	0.01
	Slope	40,620,315
	Total Sum of Squares	1339506.7T

Bioventus Total Assets History

	2025	790.1 M
	2024	728 M
	2023	810.9 M
	2022	1.4 B
	2021	1.2 B
	2020	494.5 M
	2019	472.4 M

Other Fundumenentals of Bioventus

Intangibles To Total Assets

Bioventus Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Tangible Assets	Property Plant Equipment	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Investments	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.82	0.14	0.55	-0.24	0.88	0.84	0.07	0.97	0.79	0.65	0.96	-0.65	-0.59	0.69	0.91	0.97	0.41	0.82	-0.86	-0.71	-0.19	-0.19	-0.19
Total Stockholder Equity	0.82		0.46	0.53	0.24	0.48	0.49	0.56	0.67	0.43	0.4	0.77	-0.58	-0.61	0.41	0.63	0.87	0.64	0.41	-0.59	-0.41	-0.04	-0.04	-0.04
Current Deferred Revenue	0.14	0.46		0.16	0.49	-0.27	0.09	0.86	-0.01	0.13	-0.11	-0.04	0.28	0.3	0.15	-0.13	0.19	0.92	-0.16	0.1	0.34	0.33	0.33	0.33
Net Debt	0.55	0.53	0.16		0.29	0.43	0.28	0.26	0.52	0.23	0.28	0.6	-0.24	-0.47	0.16	0.46	0.51	0.21	0.28	-0.25	-0.32	0.61	0.61	0.61
Retained Earnings	-0.24	0.24	0.49	0.29		-0.55	-0.63	0.75	-0.38	-0.65	-0.45	-0.18	0.29	0.04	-0.49	-0.53	-0.24	0.29	-0.68	0.62	0.21	0.69	0.69	0.69
Accounts Payable	0.88	0.48	-0.27	0.43	-0.55		0.86	-0.36	0.95	0.81	0.71	0.89	-0.65	-0.55	0.66	0.93	0.81	0.01	0.92	-0.88	-0.78	-0.28	-0.28	-0.28
Net Receivables	0.84	0.49	0.09	0.28	-0.63	0.86		-0.17	0.88	0.99	0.63	0.73	-0.46	-0.26	0.82	0.88	0.83	0.34	0.93	-0.89	-0.5	-0.35	-0.35	-0.35
Good Will	0.07	0.56	0.86	0.26	0.75	-0.36	-0.17		-0.14	-0.17	-0.22	-0.03	0.15	0.01	-0.14	-0.2	0.15	0.73	-0.4	0.21	0.35	0.44	0.44	0.44
Total Liab	0.97	0.67	-0.01	0.52	-0.38	0.95	0.88	-0.14		0.84	0.68	0.96	-0.61	-0.51	0.72	0.92	0.91	0.26	0.9	-0.86	-0.79	-0.22	-0.22	-0.22
Total Current Assets	0.79	0.43	0.13	0.23	-0.65	0.81	0.99	-0.17	0.84		0.6	0.65	-0.41	-0.19	0.85	0.84	0.78	0.39	0.92	-0.87	-0.43	-0.36	-0.36	-0.36
Short Term Debt	0.65	0.4	-0.11	0.28	-0.45	0.71	0.63	-0.22	0.68	0.6		0.64	-0.64	-0.47	0.66	0.69	0.6	0.13	0.72	-0.68	-0.47	-0.29	-0.29	-0.29
Intangible Assets	0.96	0.77	-0.04	0.6	-0.18	0.89	0.73	-0.03	0.96	0.65	0.64		-0.68	-0.67	0.57	0.87	0.91	0.22	0.77	-0.79	-0.83	-0.13	-0.13	-0.13
Common Stock	-0.65	-0.58	0.28	-0.24	0.29	-0.65	-0.46	0.15	-0.61	-0.41	-0.64	-0.68		0.91	-0.54	-0.77	-0.7	-0.07	-0.64	0.78	0.43	0.41	0.41	0.41
Net Tangible Assets	-0.59	-0.61	0.3	-0.47	0.04	-0.55	-0.26	0.01	-0.51	-0.19	-0.47	-0.67	0.91		-0.24	-0.67	-0.64	0.04	-0.41	0.61	0.4	0.16	0.16	0.16
Property Plant Equipment	0.69	0.41	0.15	0.16	-0.49	0.66	0.82	-0.14	0.72	0.85	0.66	0.57	-0.54	-0.24		0.73	0.67	0.42	0.87	-0.77	-0.33	-0.3	-0.3	-0.3
Long Term Debt	0.91	0.63	-0.13	0.46	-0.53	0.93	0.88	-0.2	0.92	0.84	0.69	0.87	-0.77	-0.67	0.73		0.92	0.19	0.92	-0.97	-0.59	-0.35	-0.35	-0.35
Net Invested Capital	0.97	0.87	0.19	0.51	-0.24	0.81	0.83	0.15	0.91	0.78	0.6	0.91	-0.7	-0.64	0.67	0.92		0.47	0.78	-0.89	-0.57	-0.25	-0.25	-0.25
Long Term Investments	0.41	0.64	0.92	0.21	0.29	0.01	0.34	0.73	0.26	0.39	0.13	0.22	-0.07	0.04	0.42	0.19	0.47		0.17	-0.24	0.14	0.13	0.13	0.13
Short Long Term Debt	0.82	0.41	-0.16	0.28	-0.68	0.92	0.93	-0.4	0.9	0.92	0.72	0.77	-0.64	-0.41	0.87	0.92	0.78	0.17		-0.92	-0.62	-0.4	-0.4	-0.4
Capital Stock	-0.86	-0.59	0.1	-0.25	0.62	-0.88	-0.89	0.21	-0.86	-0.87	-0.68	-0.79	0.78	0.61	-0.77	-0.97	-0.89	-0.24	-0.92		0.51	0.53	0.53	0.53
Net Working Capital	-0.71	-0.41	0.34	-0.32	0.21	-0.78	-0.5	0.35	-0.79	-0.43	-0.47	-0.83	0.43	0.4	-0.33	-0.59	-0.57	0.14	-0.62	0.51		0.2	0.2	0.2
Short Term Investments	-0.19	-0.04	0.33	0.61	0.69	-0.28	-0.35	0.44	-0.22	-0.36	-0.29	-0.13	0.41	0.16	-0.3	-0.35	-0.25	0.13	-0.4	0.53	0.2		1.0	1.0
Capital Surpluse	-0.19	-0.04	0.33	0.61	0.69	-0.28	-0.35	0.44	-0.22	-0.36	-0.29	-0.13	0.41	0.16	-0.3	-0.35	-0.25	0.13	-0.4	0.53	0.2	1.0		1.0
Deferred Long Term Liab	-0.19	-0.04	0.33	0.61	0.69	-0.28	-0.35	0.44	-0.22	-0.36	-0.29	-0.13	0.41	0.16	-0.3	-0.35	-0.25	0.13	-0.4	0.53	0.2	1.0	1.0

Click cells to compare fundamentals

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	728 M	790.1 M
Intangibles To Total Assets	0.57	0.72

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC